Opioids Market Size, Share & Trends Analysis Report By Product (IR/ Short Acting Opioids, ER/Long-Acting Opioids), By Application (Pain Relief, Anesthesia), By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
Opioids Market Growth & Trends
The global opioids market size is expected to reach USD 25.33 billion by 2030, registering CAGR of 1.2% during the forecast period, according to a new study by Grand View Research Inc. Supportive regulatory policies aid manufacturers to introduce products that may contribute to the market growth. For instance, in June 2021, the U.S. FDA approved nalmefene hydrochloride injection developed by Purdue Pharma L.P.Nalmefene injectable is an opioid antagonist designed to reverse opioid overdose. The expected approval of a product is anticipated to drive the growth.
Moreover, in June 2021, morphine sulfate tablets and morphine sulfate oral solution were approved by FDA for the management of severe pain in pediatric and adult patients for whom other treatment options were less. Thus, approval of new opioid and their launch is also expected to drive the growth.
Growing use of the opioids for the management of post-operative pain, caused due to the surgeries, is expected to drive the market growth. According to the Canadian Centre on Substance Use and Addiction, in 2020, approximately 11.8% of all the population used opioid analgesics for the management of symptoms. Tramadol and codeine are frequently dispensed for the postoperative opioid prescription in surgeries within the region.
Emergence of non-addictive alternative products to opioids for the pain-management leads to decline in the growth of opioid market. According to American Society of Anesthesiologists, there are several non-opioid medicines that are available over the counter steroids and NSAIDs such as aspirin, ibuprofen, and acetaminophen among others. Furthermore, wide availability and low cost associated with these drugs contribute to increase in demand for such products during the forecast period. For instance, aspirin cost USD 10 for a pack of 30 tablets.
In addition, in February 2022, the U.S. FDA has undertaken an initiative to encourage the development of non-addictive analgesics alternatives to opioids under its HHS overdose prevention strategy for the management of acute and chronic pain. The regulatory agency issued recommendation to pharmaceutical companies to develop non-opioid analgesic products. Such initiatives may restrain the overall growth of the opioids market.
Opioids Market Report Highlights
Opioids Market Growth & Trends
The global opioids market size is expected to reach USD 25.33 billion by 2030, registering CAGR of 1.2% during the forecast period, according to a new study by Grand View Research Inc. Supportive regulatory policies aid manufacturers to introduce products that may contribute to the market growth. For instance, in June 2021, the U.S. FDA approved nalmefene hydrochloride injection developed by Purdue Pharma L.P.Nalmefene injectable is an opioid antagonist designed to reverse opioid overdose. The expected approval of a product is anticipated to drive the growth.
Moreover, in June 2021, morphine sulfate tablets and morphine sulfate oral solution were approved by FDA for the management of severe pain in pediatric and adult patients for whom other treatment options were less. Thus, approval of new opioid and their launch is also expected to drive the growth.
Growing use of the opioids for the management of post-operative pain, caused due to the surgeries, is expected to drive the market growth. According to the Canadian Centre on Substance Use and Addiction, in 2020, approximately 11.8% of all the population used opioid analgesics for the management of symptoms. Tramadol and codeine are frequently dispensed for the postoperative opioid prescription in surgeries within the region.
Emergence of non-addictive alternative products to opioids for the pain-management leads to decline in the growth of opioid market. According to American Society of Anesthesiologists, there are several non-opioid medicines that are available over the counter steroids and NSAIDs such as aspirin, ibuprofen, and acetaminophen among others. Furthermore, wide availability and low cost associated with these drugs contribute to increase in demand for such products during the forecast period. For instance, aspirin cost USD 10 for a pack of 30 tablets.
In addition, in February 2022, the U.S. FDA has undertaken an initiative to encourage the development of non-addictive analgesics alternatives to opioids under its HHS overdose prevention strategy for the management of acute and chronic pain. The regulatory agency issued recommendation to pharmaceutical companies to develop non-opioid analgesic products. Such initiatives may restrain the overall growth of the opioids market.
Opioids Market Report Highlights
- By product, ER/long acting opioids segment held the largest market share in 2021 due to the increasing approval and launch of the novel ER/ long-acting opioids. For instance, in June 2021, the U.S. FDA accepted a review application for a new drug application for buprenorphine (Brixadi) for the pain management. Buprenorphine is an extended release long-acting opioid drug
- By application, pain relief segment dominated the opioids market in 2021 and is expected to witness significant market growth owing to increasing prevalence of the patients with chronic pain. According to the Canadian Institute for Health Information and Canadian Pain Task Force report of 2021, 1 in every 5 adults in Canada suffers from chronic pain
- By route of administration, injectable segment dominated the opioids market in 2021. This dominance can be attributed to wide availability of products used for the treatment of chronic pain and increased procedures requiring anesthesia
- By distribution channel, retail pharmacy dominated the opioids market in 2021. The availability of retail pharmacies with high dispensing rate of opioid driving segment growth
- Asia pacific is expected to be the fastest growing region during the forecast period. The growth of the region can be attributed to increasing geriatric population which are susceptible to the chronic pain
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market segmentation
1.1.1 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’S internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.3.6 List of primary sources
1.4 Information or data analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Abbreviations
1.11 Objectives
1.11.1 Objective
1.11.2 Objective
1.11.3 Objective
1.11.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Regulatory framework
3.3 Penetration and Growth Prospect Mapping
3.4 Pipeline Analysis
3.5 Market Dynamics
3.5.1 Market driver analysis
3.5.2 Market restraint analysis
3.6 PESTEL Analysis
CHAPTER 4 GLOBAL OPIOIDS MARKET - SEGMENT ANALYSIS, BY PRODUCT, 2018 - 2030 (USD MILLION)
4.1 Global Opioids Market: Product Movement Analysis
4.2 IR/ Short Acting Opioids
4.2.1 IR/ short acting opioids market estimates and forecast, 2018 - 2030 (USD Million)
4.3 ER/Long Acting Opioids
4.3.1 ER/long acting opioids market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 5 GLOBAL OPIOIDS MARKET - SEGMENT ANALYSIS, BY APPLICATION, 2018 - 2030 (USD MILLION)
5.1 Global Opioids Market: Application Movement Analysis
5.2 Pain relief
5.2.1 Pain relief market estimates and forecast, 2018 - 2030 (USD Million)
5.3 Anesthesia
5.3.1 Anesthesia market estimates and forecast, 2018 - 2030 (USD Million)
5.4 Cough suppression
5.4.1 Cough suppression market estimates and forecast, 2018 - 2030 (USD Million)
5.5 Diarrhoea suppression
5.5.1 Diarrhoea suppression market estimates and forecast, 2018 - 2030 (USD Million)
5.6 De-addiction
5.6.1 De-addiction market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6 GLOBAL OPIOIDS MARKET - SEGMENT ANALYSIS, BY ROUTE OF ADMINISTRATION, 2018 - 2030 (USD MILLION)
6.1 Global Opioids Market: Route of Administration Movement Analysis
6.2 Oral
6.2.1 Oral market estimates and forecast, 2018 - 2030 (USD Million)
6.3 Injectable
6.3.1 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
6.4 Others
6.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7 GLOBAL OPIOIDS MARKET - SEGMENT ANALYSIS, BY DISTRIBUTION CHANNEL, 2018 - 2030 (USD MILLION)
7.1 Global Opioids Market: Distribution Channel Movement Analysis
7.2 Hospital Pharmacy
7.2.1 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
7.3 Retail Pharmacy
7.3.1 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
7.4 Others
7.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8 OPIOIDS MARKET: SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
8.1 Opioids Market: Regional Movement Analysis
8.1.1 North America
8.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
8.1.1.2 U.S.
8.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
8.1.1.3 Canada
8.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2 Europe
8.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.2 UK
8.1.2.2.1 UK market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.3 Germany
8.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.4 France
8.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.5 Spain
8.1.2.5.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.6 Italy
8.1.2.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3 Asia Pacific
8.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.2 Japan
8.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.3 China
8.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.4 India
8.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.5 Australia
8.1.3.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.6 South Korea
8.1.3.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4 Latin America
8.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.2 Brazil
8.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.3 Mexico
8.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.4 Argentina
8.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5 Middle East & Africa
8.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.2 South Africa
8.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.3 Saudi Arabia
8.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.4 United Arab Emirate
8.1.5.4.1 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 9 GLOBAL OPIOIDS MARKET: COMPETITIVE ANALYSIS
9.1 Recent Developments and Impact Analysis, by Key Market Participants
9.1.1 Major deals & strategic alliances analysis
9.1.1.1 New Product Launches
9.1.1.2 Mergers and Acquisitions
9.1.1.3 Partnerships & Agreements
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.2.3 Emerging Players
9.2.4 Heat Map Analysis
9.3 Company Market Position Analysis
9.4 Vendor Landscape
9.4.1 List of Key Distributors and Channel Partners
9.4.2 List of Potential End Users
9.4.3 Key Company Market Share Analysis, 2021
9.5 Company Market Share, 2021
9.5.1 Competitive Dashboard Analysis
9.6 Private Companies
9.6.1 List of Key Emerging Companies
9.6.2 Regional Network Map
9.7 Company Profiles
9.7.1 Purdue Pharma L.P.
9.7.1.1 Company overview
9.7.1.2 Financial performance
9.7.1.3 Product benchmarking
9.7.1.4 Strategic initiatives
9.7.2 Johnson & Johnson Services, Inc.
9.7.2.1 Company overview
9.7.2.2 Financial performance
9.7.2.3 Product benchmarking
9.7.2.4 Strategic initiatives
9.7.3 Hikma Pharmaceuticals PLC
9.7.3.1 Company overview
9.7.3.2 Financial performance
9.7.3.3 Product benchmarking
9.7.3.4 Strategic initiatives
9.7.4 Pfizer Inc.
9.7.4.1 Company overview
9.7.4.2 Financial performance
9.7.4.3 Product benchmarking
9.7.4.4 Strategic initiatives
9.7.5 AbbVie Inc.
9.7.5.1 Company overview
9.7.5.2 Financial performance
9.7.5.3 Product benchmarking
9.7.5.4 Strategic initiatives
9.7.6 Sanofi
9.7.6.1 Company overview
9.7.6.2 Product benchmarking
9.7.6.3 Strategic initiatives
9.7.7 Sun Pharmaceutical Industries Ltd
9.7.7.1 Company overview
9.7.7.2 Financial performance
9.7.7.3 Product benchmarking
9.7.8 Gr?nenthal
9.7.8.1 Company overview
9.7.8.2 Financial performance
9.7.8.3 Product benchmarking
9.7.8.4 Strategic initiatives
9.7.9 Merck & Co., Inc.
9.7.9.1 Company overview
9.7.9.2 Financial performance
9.7.9.3 Product benchmarking
9.7.9.4 Strategic initiatives
1.1 Market segmentation
1.1.1 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’S internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.3.6 List of primary sources
1.4 Information or data analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Abbreviations
1.11 Objectives
1.11.1 Objective
1.11.2 Objective
1.11.3 Objective
1.11.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Regulatory framework
3.3 Penetration and Growth Prospect Mapping
3.4 Pipeline Analysis
3.5 Market Dynamics
3.5.1 Market driver analysis
3.5.2 Market restraint analysis
3.6 PESTEL Analysis
CHAPTER 4 GLOBAL OPIOIDS MARKET - SEGMENT ANALYSIS, BY PRODUCT, 2018 - 2030 (USD MILLION)
4.1 Global Opioids Market: Product Movement Analysis
4.2 IR/ Short Acting Opioids
4.2.1 IR/ short acting opioids market estimates and forecast, 2018 - 2030 (USD Million)
4.3 ER/Long Acting Opioids
4.3.1 ER/long acting opioids market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 5 GLOBAL OPIOIDS MARKET - SEGMENT ANALYSIS, BY APPLICATION, 2018 - 2030 (USD MILLION)
5.1 Global Opioids Market: Application Movement Analysis
5.2 Pain relief
5.2.1 Pain relief market estimates and forecast, 2018 - 2030 (USD Million)
5.3 Anesthesia
5.3.1 Anesthesia market estimates and forecast, 2018 - 2030 (USD Million)
5.4 Cough suppression
5.4.1 Cough suppression market estimates and forecast, 2018 - 2030 (USD Million)
5.5 Diarrhoea suppression
5.5.1 Diarrhoea suppression market estimates and forecast, 2018 - 2030 (USD Million)
5.6 De-addiction
5.6.1 De-addiction market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6 GLOBAL OPIOIDS MARKET - SEGMENT ANALYSIS, BY ROUTE OF ADMINISTRATION, 2018 - 2030 (USD MILLION)
6.1 Global Opioids Market: Route of Administration Movement Analysis
6.2 Oral
6.2.1 Oral market estimates and forecast, 2018 - 2030 (USD Million)
6.3 Injectable
6.3.1 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
6.4 Others
6.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7 GLOBAL OPIOIDS MARKET - SEGMENT ANALYSIS, BY DISTRIBUTION CHANNEL, 2018 - 2030 (USD MILLION)
7.1 Global Opioids Market: Distribution Channel Movement Analysis
7.2 Hospital Pharmacy
7.2.1 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
7.3 Retail Pharmacy
7.3.1 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
7.4 Others
7.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8 OPIOIDS MARKET: SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
8.1 Opioids Market: Regional Movement Analysis
8.1.1 North America
8.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
8.1.1.2 U.S.
8.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
8.1.1.3 Canada
8.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2 Europe
8.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.2 UK
8.1.2.2.1 UK market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.3 Germany
8.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.4 France
8.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.5 Spain
8.1.2.5.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.6 Italy
8.1.2.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3 Asia Pacific
8.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.2 Japan
8.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.3 China
8.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.4 India
8.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.5 Australia
8.1.3.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.6 South Korea
8.1.3.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4 Latin America
8.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.2 Brazil
8.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.3 Mexico
8.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.4 Argentina
8.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5 Middle East & Africa
8.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.2 South Africa
8.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.3 Saudi Arabia
8.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.4 United Arab Emirate
8.1.5.4.1 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 9 GLOBAL OPIOIDS MARKET: COMPETITIVE ANALYSIS
9.1 Recent Developments and Impact Analysis, by Key Market Participants
9.1.1 Major deals & strategic alliances analysis
9.1.1.1 New Product Launches
9.1.1.2 Mergers and Acquisitions
9.1.1.3 Partnerships & Agreements
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.2.3 Emerging Players
9.2.4 Heat Map Analysis
9.3 Company Market Position Analysis
9.4 Vendor Landscape
9.4.1 List of Key Distributors and Channel Partners
9.4.2 List of Potential End Users
9.4.3 Key Company Market Share Analysis, 2021
9.5 Company Market Share, 2021
9.5.1 Competitive Dashboard Analysis
9.6 Private Companies
9.6.1 List of Key Emerging Companies
9.6.2 Regional Network Map
9.7 Company Profiles
9.7.1 Purdue Pharma L.P.
9.7.1.1 Company overview
9.7.1.2 Financial performance
9.7.1.3 Product benchmarking
9.7.1.4 Strategic initiatives
9.7.2 Johnson & Johnson Services, Inc.
9.7.2.1 Company overview
9.7.2.2 Financial performance
9.7.2.3 Product benchmarking
9.7.2.4 Strategic initiatives
9.7.3 Hikma Pharmaceuticals PLC
9.7.3.1 Company overview
9.7.3.2 Financial performance
9.7.3.3 Product benchmarking
9.7.3.4 Strategic initiatives
9.7.4 Pfizer Inc.
9.7.4.1 Company overview
9.7.4.2 Financial performance
9.7.4.3 Product benchmarking
9.7.4.4 Strategic initiatives
9.7.5 AbbVie Inc.
9.7.5.1 Company overview
9.7.5.2 Financial performance
9.7.5.3 Product benchmarking
9.7.5.4 Strategic initiatives
9.7.6 Sanofi
9.7.6.1 Company overview
9.7.6.2 Product benchmarking
9.7.6.3 Strategic initiatives
9.7.7 Sun Pharmaceutical Industries Ltd
9.7.7.1 Company overview
9.7.7.2 Financial performance
9.7.7.3 Product benchmarking
9.7.8 Gr?nenthal
9.7.8.1 Company overview
9.7.8.2 Financial performance
9.7.8.3 Product benchmarking
9.7.8.4 Strategic initiatives
9.7.9 Merck & Co., Inc.
9.7.9.1 Company overview
9.7.9.2 Financial performance
9.7.9.3 Product benchmarking
9.7.9.4 Strategic initiatives
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Opioids Market, By Region, 2018 - 2030 (USD Million)
Table 4 Global Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 5 Global Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 6 GlobalOpioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 7 GlobalOpioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 8 North America Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 9 North America Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 10 North America Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 11 North America Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 12 U.S. Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 13 U.S. Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 14 U.S. Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 15 U.S. Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 16 Canada Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 17 Canada Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 18 Canada Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 19 Canada Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 20 Europe Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 21 Europe Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 22 Europe Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 23 Europe Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 24 Germany Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 25 Germany Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 26 Germany Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 27 Germany Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 28 UK Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 29 UK Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 30 UK Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 31 UK Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 32 France Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 33 France Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 34 France Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 35 France Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 36 Italy Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 37 Italy Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 38 Italy Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 39 Italy Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 40 Spain Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 41 Spain Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 42 Spain Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 43 Spain Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 48 Japan Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 49 Japan Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 50 Japan Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 51 Japan Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 52 China Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 53 China Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 54 China Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 55 China Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 56 India Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 57 India Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 58 India Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 59 India Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 60 South Korea Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 61 South Korea Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 62 South Korea Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 63 South Korea Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 64 Australia Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 65 Australia Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 66 Australia Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 67 Australia Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 68 Latin America Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 69 Latin America Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 70 Latin America Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 71 Latin America Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 72 Brazil Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 73 Brazil Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 74 Brazil Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 75 Brazil Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 76 Mexico Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 77 Mexico Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 78 Mexico Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 79 Mexico Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 80 Argentina Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 81 Argentina Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 82 Argentina Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 83 Argentina Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 84 Middle East & Africa Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 85 Middle East & Africa Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 86 Middle East & Africa Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 87 Middle East & Africa Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 90 Saudi Arabia Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 91 Saudi Arabia Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 92 South Africa Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 93 South Africa Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 94 South Africa Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 95 South Africa Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 96 UAE Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 97 UAE Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 98 UAE Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 99 UAE Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Opioids Market, By Region, 2018 - 2030 (USD Million)
Table 4 Global Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 5 Global Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 6 GlobalOpioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 7 GlobalOpioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 8 North America Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 9 North America Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 10 North America Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 11 North America Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 12 U.S. Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 13 U.S. Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 14 U.S. Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 15 U.S. Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 16 Canada Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 17 Canada Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 18 Canada Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 19 Canada Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 20 Europe Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 21 Europe Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 22 Europe Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 23 Europe Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 24 Germany Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 25 Germany Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 26 Germany Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 27 Germany Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 28 UK Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 29 UK Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 30 UK Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 31 UK Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 32 France Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 33 France Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 34 France Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 35 France Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 36 Italy Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 37 Italy Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 38 Italy Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 39 Italy Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 40 Spain Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 41 Spain Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 42 Spain Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 43 Spain Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 48 Japan Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 49 Japan Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 50 Japan Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 51 Japan Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 52 China Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 53 China Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 54 China Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 55 China Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 56 India Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 57 India Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 58 India Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 59 India Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 60 South Korea Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 61 South Korea Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 62 South Korea Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 63 South Korea Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 64 Australia Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 65 Australia Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 66 Australia Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 67 Australia Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 68 Latin America Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 69 Latin America Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 70 Latin America Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 71 Latin America Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 72 Brazil Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 73 Brazil Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 74 Brazil Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 75 Brazil Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 76 Mexico Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 77 Mexico Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 78 Mexico Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 79 Mexico Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 80 Argentina Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 81 Argentina Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 82 Argentina Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 83 Argentina Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 84 Middle East & Africa Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 85 Middle East & Africa Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 86 Middle East & Africa Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 87 Middle East & Africa Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 90 Saudi Arabia Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 91 Saudi Arabia Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 92 South Africa Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 93 South Africa Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 94 South Africa Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 95 South Africa Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 96 UAE Opioids Market, By Product, 2018 - 2030 (USD Million)
Table 97 UAE Opioids Market, By Application, 2018 - 2030 (USD Million)
Table 98 UAE Opioids Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 99 UAE Opioids Market, By Distribution Channel, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Opioids market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Opioids market snapshot
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook, revenue, 2021 (USD Million)
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Opioids market driver impact
Fig. 14 Opioids market restraint impact
Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 16 Industry Analysis - Porter’s
Fig. 17 Strategy mapping
Fig. 18 Opioids market: Product outlook and key takeaways
Fig. 19 Opioids market: Product movement analysis & market share 2021 & 2030
Fig. 20 IR/short acting opioids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 ER/long acting opioids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Opioids market: Application outlook and key takeaways
Fig. 23 Opioids market: Application movement analysis & market share 2021 & 2030
Fig. 24 Pain relief market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Anaesthesia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Cough suppression market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Diarrhoea suppression market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 De-addiction market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Opioids market: Route of administration outlook and key takeaways
Fig. 30 Opioids market: Route of administration movement analysis & market share 2021 & 2030
Fig. 31 Oral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Opioids market: Distribution channel outlook and key takeaways
Fig. 35 Opioids market: Distribution channel movement analysis & market share 2021 & 2030
Fig. 36 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Opioids: Regional outlook and key takeaways
Fig. 40 Regional outlook, 2021 & 2030
Fig. 41 North America
Fig. 42 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 U.S.
Fig. 44 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Canada
Fig. 46 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Europe
Fig. 48 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 UK
Fig. 50 UK market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Germany
Fig. 52 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 France
Fig. 54 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Italy
Fig. 56 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Spain
Fig. 58 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Asia-Pacific
Fig. 60 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Japan
Fig. 62 Japan market estimates and forecast, 2018 - 2030(USD Million)
Fig. 63 China
Fig. 64 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 India
Fig. 66 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 South Korea
Fig. 68 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Australia
Fig. 70 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Latin America
Fig. 72 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Brazil
Fig. 74 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Mexico
Fig. 76 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Argentina
Fig. 78 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 Middle East & Africa
Fig. 80 MEA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 81 South Africa
Fig. 82 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 Saudi Arabia
Fig. 84 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 UAE
Fig. 86 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 Market differentiators
Fig. 88 Key company market share analysis, 2021
Fig. 89 Company market position analysis
Fig. 90 Competitive dashboard analysis
Fig. 91 Regional network map
Fig. 1 Opioids market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Opioids market snapshot
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook, revenue, 2021 (USD Million)
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Opioids market driver impact
Fig. 14 Opioids market restraint impact
Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 16 Industry Analysis - Porter’s
Fig. 17 Strategy mapping
Fig. 18 Opioids market: Product outlook and key takeaways
Fig. 19 Opioids market: Product movement analysis & market share 2021 & 2030
Fig. 20 IR/short acting opioids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 ER/long acting opioids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Opioids market: Application outlook and key takeaways
Fig. 23 Opioids market: Application movement analysis & market share 2021 & 2030
Fig. 24 Pain relief market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Anaesthesia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Cough suppression market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Diarrhoea suppression market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 De-addiction market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Opioids market: Route of administration outlook and key takeaways
Fig. 30 Opioids market: Route of administration movement analysis & market share 2021 & 2030
Fig. 31 Oral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Opioids market: Distribution channel outlook and key takeaways
Fig. 35 Opioids market: Distribution channel movement analysis & market share 2021 & 2030
Fig. 36 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Opioids: Regional outlook and key takeaways
Fig. 40 Regional outlook, 2021 & 2030
Fig. 41 North America
Fig. 42 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 U.S.
Fig. 44 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Canada
Fig. 46 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Europe
Fig. 48 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 UK
Fig. 50 UK market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Germany
Fig. 52 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 France
Fig. 54 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Italy
Fig. 56 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Spain
Fig. 58 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Asia-Pacific
Fig. 60 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Japan
Fig. 62 Japan market estimates and forecast, 2018 - 2030(USD Million)
Fig. 63 China
Fig. 64 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 India
Fig. 66 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 South Korea
Fig. 68 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Australia
Fig. 70 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Latin America
Fig. 72 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Brazil
Fig. 74 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Mexico
Fig. 76 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Argentina
Fig. 78 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 Middle East & Africa
Fig. 80 MEA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 81 South Africa
Fig. 82 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 Saudi Arabia
Fig. 84 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 UAE
Fig. 86 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 Market differentiators
Fig. 88 Key company market share analysis, 2021
Fig. 89 Company market position analysis
Fig. 90 Competitive dashboard analysis
Fig. 91 Regional network map
